653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors
Authors:
- J. WangJWJ. Wang
- J. ZhaoJZJ. Zhao
- J. ZhongJZJ. Zhong
- X. LiXLX. Li
- J. FangJFJ. Fang
- Y. YuYYY. Yu
- X. FangXFX. Fang
- J. ChangJCJ. Chang
- Z. LiuZLZ. Liu
- Y. ZhaoYZY. Zhao
- Q. SongQSQ. Song
- C. BaiCBC. Bai
- 20 October 2023
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 34, S459